Antisense Therapeutics Limited (AU:PER) has released an update.
In a significant update for investors, Platinum Investment Management Limited has reported a change in their substantial shareholding in Percheron Therapeutics Limited. The disclosure, in compliance with the Corporations Act 2001 Section 671B, reveals a shift in ownership percentage, reflecting Platinum’s dynamic portfolio adjustments. The changes in shareholdings are indicative of Platinum’s ongoing strategic investment decisions in the biotech sector.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
